The Introduction of Generic Risperidone in Medicare Part D

OBJECTIVES: The introduction of generic second-generation antipsychotics (SGAs), starting with risperidone in July 2008, could reduce antipsychotic spending and cost-related use barriers. This study examines associations between generic risperidone use and spending and adherence after introduction a...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Am J Manag Care
Main Authors: Fung, Vicki, Price, Mary, Busch, Alisa B., Landrum, Mary Beth, Fireman, Bruce, Nierenberg, Andrew A., Newhouse, Joseph P., Hsu, John
Formato: Artigo
Idioma:Inglês
Publicado: 2016
Assuntos:
Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC4915110/
https://ncbi.nlm.nih.gov/pubmed/26799124
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares